Biofield Corp. is a medical device company specializing in the development and marketing of a revolutionary patented device for diagnosing breast cancer.

The Biofield Diagnostic System (BDS) is non-invasive and provides an objective accurate result in 5 minutes to the doctor and patient.

Used as an adjunct to physical exam and imaging, clinical data has shown that the potential for missed diagnosis is reduced.

Like an EKG, the technology measures electro potential differences in the breast tissue with single-use, disposable sensors the size of a quarter, using a briefcase sized device.

The Biofield Diagnostic System test detects differences in direct current in cells with rapid or abnormal growth patterns such as those found in cancer.

In addition to accuracy, the technology is affordable, as the price of a system is less than 20% of the cost of a mammography unit, and can be used in a physician's office, or even a remote location.